<DOC>
	<DOCNO>NCT01809171</DOCNO>
	<brief_summary>The third generation oral aromatase inhibitor ( AIs ) increasingly used management estrogen receptor positive breast cancer . One issue relate administration oral AIs side effect , particularly musculoskeletal system . Although prevalence importance arthralgia myalgia occur BC patient receive adjuvant AIs evident , mechanism clearly explain invalidate symptom unknown . In project , aim unravel interaction vitamin D musculoskeletal adverse event experience AI user . We also evaluate vitamin D supplementation affect AI-induced musculoskeletal symptom breast cancer patient , mean randomize placebo-controlled double blind clinical trial . We assess change musculoskeletal system use magnetic resonance imaging joint , hand grip strength also monitor serum IGF-I estrogen level together bone resorption formation marker .</brief_summary>
	<brief_title>Placebo-controlled Trial With Vitamin D Prevent Worsening/Relieve Aromatase Inhibitor-induced Musculoskeletal Symptoms Breast Cancer Patients</brief_title>
	<detailed_description />
	<mesh_term>Breast Neoplasms</mesh_term>
	<mesh_term>Musculoskeletal Diseases</mesh_term>
	<mesh_term>Vitamins</mesh_term>
	<mesh_term>Vitamin D</mesh_term>
	<mesh_term>Ergocalciferols</mesh_term>
	<mesh_term>Cholecalciferol</mesh_term>
	<mesh_term>Aromatase Inhibitors</mesh_term>
	<criteria>Postmenopausal status Currently treat AI adjuvant setting ( minimum 8 week ) AIMSS determine new worsened musculoskeletal complaint follow AI therapy Vitamin D deficiency ( &lt; 30ng/ml ) Caucasian Hormone replacement therapy last 6 month Current use last 12 month bisphosphonates Tamoxifen use last 6 month History kidney stone History hypercalcemia/hypercalciuria hyperthyroidism Paget 's disease bone Current use Digitalis/digoxin thiazide diuretic Current use vitamin D ( multivitamin ) supplementation stop</criteria>
	<gender>Female</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>October 2015</verification_date>
</DOC>